ADPT vs MRK · rev $142.4M vs P/E 33, rev $16.61B
Adaptive Biotechnologies Corp (ADPT) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
ADPT currently screens at market cap $2.69B. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the ADPT and MRK stock pages for the full models.
Not investment advice.